In this video, Raymond Cross, MD, from the University of Maryland, addresses the most challenging extraintestinal manifestations among patients with inflammatory bowel disease.
Santosh Kesari, MD, PhD, discusses a new prodrug that targets cells with a high level of PSMA expression, a protein that is present in many cancerous tumors.
Three researchers from the Wolfson Institute for Preventative Medicine, Queen Mary University and The London Hospital offered the argument for just that in the British Journal of Medicine.
Douglas Leventhal, MD, who is an ear, nose, and throat specialist at ENT and Allergy Associates in Oradell, New Jersey, walks through the steps of a septoplasty.
